Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod

Afsoon Ghafari-Saravi; Alana Haussmann; Jessica Wu; Kyle Cheng

doi:10.1016/j.jdcr.2024.03.005

Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod

JAAD Case Rep. 2024 Mar 15:47:68-71. doi: 10.1016/j.jdcr.2024.03.005. eCollection 2024 May.

Authors

Afsoon Ghafari-Saravi¹, Alana Haussmann², Jessica Wu³, Kyle Cheng³

Affiliations

¹ Department of Dermatology, Oregon Health & Science University, School of Medicine, Portland, Oregon.
² Department of Rheumatology, University of California Los Angeles, Los Angeles, California.
³ Department of Dermatology, University of California Los Angeles, Los Angeles, California.

No abstract available

Keywords: P-ANCA vasculitis; autoimmune disease; efgartigimod; immunomodulatory therapy; perinuclear anti-neutrophil cytoplasmic antibodies; vasculitis.

Publication types

Case Reports